When we transplanted these relapsed tumors into NSG mice and administered fresh EpCAM CAR T cell products, we observed a modest partial response to CAR T cell therapy, despite a substantial expansion of CAR T cells within the tumor. The gene discussed is EPCAM; the disease is neoplasm.